Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurofilaments

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Alzheimer’s Disease

cognitive testing2 - alzheimer's disease symptoms1 - imbecility1 - atherosclerotic plaques2 - risk of alzheimer's3 - movement disorder2 - parkinsonism1 - parkinsons diagnosis1 - declines in memory1 - parkinson's disease risk1 - memory disorder1 - leg tremors1 - general anesthesia1 - neu11 - alzheimer's process1 - caffeine2 - mri2 - dementiaantipsychotic drugs1 - atherosclerosis7 - vascular health1 - brain disorder1 - insomnia2 - alzheimer's risk4 - astro-gliosis1 - confabulatory euphoria1 - dementia and down’s syndrome1 - arthritis1 - cardiac arrest1 - knopman1 - menopause1 -